The BRAINTEASER community of practice will focus on the clinical use of Artificial Intelligence and digital tools to manage ALS and MS disease. It will be an innovation community to create new breakthrough ideas, approaches, and knowledge. The community will target academia (student and researchers), health care providers (medical specialists, nurses), patients and care-givers representatives (associations or patients) and companies interested in the digital health market. The Community of Practice will arrange a set of activities to engage the community to generate new knowledge on the following areas:
· Trustworthy AI based solutions for ALS and MS
· Service design of novel solutions and business for MS and ALS
· Novel treatments, diagnostics, clinical practices
· Standardisation and regulation of the digital technologies
During 2022 the project will kick off the first activities related to the use of the BRAINTEASER patient app and clinical tools. A set of workshops will be arranged to study the adoption of the solution in the local communities where the system will be deployed (Madrid, Lisbon, Torino and Pavia) and to discuss the clinical usage of the system.
